(File Photo: IANS)

Covishield will be commercialised once trials are successful: SII

New Delhi: Serum Institute of India, has clarified that the current claims surrounding Covishield’s availability in the media are completely false and conjectural. “Presently, the government has granted us permission to only manufacture the vaccine and stockpile it for future use”, SII said in a statement. “Covishield will be commercialised once the trials are proven […]

Image For Representation (IANS)

Serum Institute of India to produce 100 million doses of Covid Vaccine

New Delhi: Serum Institute of India (SII), the worlds largest vaccine manufacturer by volume, has entered into a new landmark partnership with Gavi, The Vaccine Alliance and the Bill & Melinda Gates Foundation, to accelerate the manufacture and delivery of up to 100 million doses of COVID-19 vaccines for India and low- and middle-income countries […]

Image For Representation (Photo by cottonbro from Pexels)

Serum Institute of India gets DCGI approval for clinical trials of Oxford vaccine

New Delhi: The Drugs Controller General of India (DCGI) has given approval to Pune’s Serum Institute of India (SII) to conduct clinical trials of Oxford University-Astra Zeneca COVID-19 vaccine in India. The SII received approval by the India’s top drug regulator on Sunday after a thorough evaluation based on the recommendations of the Subject Expert Committee […]

Image For Representation

Serum Institute of India to apply for Oxford vaccine trials in India in a week

New Delhi: The Serum Institute of India (SII) will soon apply to the Indian regulator for the licensure trials of the AstraZeneca-Oxford Covid vaccine. Commenting on the AstraZeneca-Oxford vaccine’s results, Adar Poonawalla, CEO, Serum Institute of India, said, “The trials have shown promising results and we are extremely happy about it. We will be applying […]